Results 11 to 20 of about 262,879 (304)

[Liver Cirrhosis].

open access: yesPraxis, 2023
Cirrhosis is a common disease with high morbidity and mortality. In industrialised countries, the most common causes of cirrhosis are the alcoholic liver disease, non-alcoholic fatty liver disease and chronic viral hepatitis. Cirrhosis is often diagnosed late, as it can be asymptomatic for a long time.
Robert, Brenig, Christine, Bernsmeier
  +7 more sources

Liver cirrhosis [PDF]

open access: yesNursing Standard, 2008
Cirrhosis is defined as the histological development of regenerative nodules surrounded by fibrous bands in response to chronic liver injury, which leads to portal hypertension and end-stage liver disease. Recent advances in the understanding of the natural history and pathophysiology of cirrhosis, and in treatment of its complications, have resulted ...
Detlef, Schuppan, Nezam H, Afdhal
openaire   +4 more sources

Computed Tomography Images of Spontaneous Portosystemic Shunt in Liver Cirrhosis

open access: yesCanadian Journal of Gastroenterology and Hepatology, 2022
Spontaneous portosystemic shunt (SPSS) refers to collateral vessels that communicate between the portal vein system and systemic circulation. SPSS mainly includes esophageal varices, gastric varices, left gastric vein, recanalized paraumbilical vein ...
Fangfang Yi   +7 more
doaj   +1 more source

Irisin in Liver Cirrhosis [PDF]

open access: yesJournal of Clinical Medicine, 2020
Background: Sarcopenia is a prevalent muscle abnormality characterized by progressive and generalized loss of skeletal muscle mass and strength, common among patients with decompensated advanced chronic liver disease (dACLD). Irisin is a recently identified myokine, which is mainly expressed and secreted by skeletal muscle.
Michał Kukla   +11 more
openaire   +3 more sources

No Association of Homocysteine, Anticardiolipin Antibody, and Anti-β2 Glycoprotein I Antibody With Portal Venous System Thrombosis in Liver Cirrhosis

open access: yesClinical and Applied Thrombosis/Hemostasis, 2021
Portal venous system thrombosis (PVST), a common complication of liver cirrhosis, is closely associated with thrombophilia. To explore the association of homocysteine (Hcy), anticardiolipin antibody (aCL), and anti-β2 glycoprotein I antibody (aβ 2 GPI ...
Le Wang   +8 more
doaj   +1 more source

Liver cirrhosis

open access: yesInternational journal of health sciences, 2022
Liver cirrhosis is a chronic liver infection. It consist of deterioration of liver cells along with fibrosis and infection generating nodules. Patients with cirrhosis frequently have either global malnutrition or alterations in specific aspects of nutritional status, such as micronutrient deficiencies, due to multiple mechanisms, including poor ...
Garima Singh   +7 more
openaire   +2 more sources

Identification of novel non-HFE mutations in Chinese patients with hereditary hemochromatosis

open access: yesOrphanet Journal of Rare Diseases, 2022
Backgrounds Hereditary hemochromatosis (HH) is mainly caused by homozygous p.C282Y mutations in HFE in the Caucasians. We recently reported non-HFE mutations constitute the major cause of HH in Chinese.
Wei Zhang   +17 more
doaj   +1 more source

Correlation of genotype and phenotype in 32 patients with hereditary hemochromatosis in China

open access: yesOrphanet Journal of Rare Diseases, 2021
Background Hereditary hemochromatosis (HH) is widely recognized and clinical manifestations of hemochromatosis-related (HFE-related) HH is well studied in European populations.
Liyan Wu   +17 more
doaj   +1 more source

CO2 or air cholangiography reduces the risk of post-ERCP cholangitis in patients with Bismuth type IV hilar biliary obstruction

open access: yesBMC Gastroenterology, 2020
Background Endoscopic biliary stenting by endoscopic retrograde cholangiopancreatography (ERCP) is the most common form of palliation for malignant hilar obstruction. However, ERCP in such cases is associated with a risk of cholangitis.
Wen-hui Zhang   +7 more
doaj   +1 more source

Fucosyltransferase 5 Promotes the Proliferative and Migratory Properties of Intrahepatic Cholangiocarcinoma Cells via Regulating Protein Glycosylation Profiles

open access: yesClinical Medicine Insights: Oncology, 2023
Background: The incidence of intrahepatic cholangiocarcinoma (ICC) is increasing globally, and its prognosis has not improved substantially in recent years. Understanding the pathogenesis of ICC may provide a theoretical basis for its treatment.
Jingheng Guo   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy